Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression of concern: "Humoral immune mechanisms involved in protective and pathological immunity during COVID-19" [Hum. Immunol. 82(10) (2021) 733-745].
Widjaja G, Jalil AT, Rahman HS, Abdelbasset WK, Bokov DO, Bokov DO, Ghaebi M, Marofi F, Navashenaq JG, Jadidi-Niaragh F, Ahmadi M. Widjaja G, et al. Among authors: marofi f. Hum Immunol. 2023 May-Jul;84(5-7):355. doi: 10.1016/j.humimm.2023.03.005. Epub 2023 Apr 8. Hum Immunol. 2023. PMID: 37271569 Free PMC article. No abstract available.
Corrigendum to "STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance" [Int. Immunopharmacol. 119 (2023) 110160].
Gharibi T, Barpour N, Hosseini A, Mohammadzadeh A, Marofi F, Ebrahimi-Kalan A, Nejati-Koshki K, Abdollahpour-Alitappeh M, Safaei S, Baghbani E, Baradaran B. Gharibi T, et al. Among authors: marofi f. Int Immunopharmacol. 2023 Jun;119:110303. doi: 10.1016/j.intimp.2023.110303. Epub 2023 May 11. Int Immunopharmacol. 2023. PMID: 37179201 No abstract available.
STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance.
Gharibi T, Barpour N, Hosseini A, Mohammadzadeh A, Marofi F, Ebrahimi-Kalan A, Nejati-Koshki K, Abdollahpour-Alitappeh M, Safaei S, Baghbani E, Baradaran B. Gharibi T, et al. Among authors: marofi f. Int Immunopharmacol. 2023 Jun;119:110160. doi: 10.1016/j.intimp.2023.110160. Epub 2023 Apr 18. Int Immunopharmacol. 2023. PMID: 37080068
Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis.
Shomali N, Baradaran B, Daei Sorkhabi A, Sarkesh A, Kahrizi MS, Tosan F, Mahmoodpoor A, Mardi A, Mohammadi H, Hassanzadeh A, Saeedi H, Hajialilo M, Hemmatzadeh M, Marofi F, Sandoghchian Shotorbani S. Shomali N, et al. Among authors: marofi f. Gene. 2022 Nov 30;844:146829. doi: 10.1016/j.gene.2022.146829. Epub 2022 Aug 19. Gene. 2022. PMID: 35995118
Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
Mohammed RN, Tamjidifar R, Rahman HS, Adili A, Ghoreishizadeh S, Saeedi H, Thangavelu L, Shomali N, Aslaminabad R, Marofi F, Tahavvori M, Danishna S, Akbari M, Ercan G. Mohammed RN, et al. Among authors: marofi f. Cell Commun Signal. 2022 Jun 15;20(1):90. doi: 10.1186/s12964-022-00913-4. Cell Commun Signal. 2022. PMID: 35705949 Free PMC article. No abstract available.
77 results